Mutually constructive roles of Ail and LPS in Yersinia pestis serum survival.


Journal

Molecular microbiology
ISSN: 1365-2958
Titre abrégé: Mol Microbiol
Pays: England
ID NLM: 8712028

Informations de publication

Date de publication:
09 2020
Historique:
received: 20 03 2020
revised: 17 05 2020
accepted: 18 05 2020
pubmed: 29 5 2020
medline: 10 6 2021
entrez: 29 5 2020
Statut: ppublish

Résumé

The outer membrane is a key virulence determinant of gram-negative bacteria. In Yersinia pestis, the deadly agent that causes plague, the protein Ail and lipopolysaccharide (LPS)

Identifiants

pubmed: 32462782
doi: 10.1111/mmi.14530
pmc: PMC7594906
doi:

Substances chimiques

Ail protein, Yersinia pestis 0
Anti-Bacterial Agents 0
Bacterial Outer Membrane Proteins 0
Lipopolysaccharides 0
Virulence Factors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

510-520

Subventions

Organisme : NCI NIH HHS
ID : P30 CA030199
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI130009
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM118186
Pays : United States

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

J Phys Chem B. 2009 Sep 17;113(37):12466-76
pubmed: 19694450
Infect Immun. 1986 Feb;51(2):445-54
pubmed: 3002984
Adv Exp Med Biol. 2007;603:88-96
pubmed: 17966406
J Biomol NMR. 1995 Jul;6(1):59-66
pubmed: 22911578
Mol Microbiol. 2004 Jun;52(5):1363-73
pubmed: 15165239
J Comput Chem. 2008 Nov 30;29(15):2543-64
pubmed: 18470966
Biophys J. 2013 Sep 17;105(6):1444-55
pubmed: 24047996
Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):E5034-43
pubmed: 27493217
Biochim Biophys Acta. 2013 Feb;1828(2):284-93
pubmed: 22960041
Biophys J. 2016 Oct 4;111(7):1409-1417
pubmed: 27705764
Structure. 2011 Nov 9;19(11):1672-82
pubmed: 22078566
Acta Naturae. 2012 Jul;4(3):46-58
pubmed: 23150803
Structure. 2000 Jun 15;8(6):585-92
pubmed: 10873859
Infect Immun. 2006 Feb;74(2):1381-6
pubmed: 16428789
J Chem Theory Comput. 2019 Jan 8;15(1):775-786
pubmed: 30525595
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11766-71
pubmed: 16864791
Annu Rev Microbiol. 2017 Sep 8;71:215-232
pubmed: 28886687
J Bacteriol. 1990 Feb;172(2):1062-9
pubmed: 1688838
J Appl Microbiol. 2000 May;88(5):784-90
pubmed: 10792538
Biochemistry. 2005 Feb 8;44(5):1731-43
pubmed: 15683257
Front Cell Infect Microbiol. 2012 Aug 06;2:103
pubmed: 22919692
Infect Immun. 2010 Mar;78(3):1163-75
pubmed: 20028810
J Med Microbiol. 2007 Apr;56(Pt 4):443-453
pubmed: 17374882
Microbiology (Reading). 2015 Nov;161(11):2174-2183
pubmed: 26377177
Infect Immun. 2009 Feb;77(2):825-36
pubmed: 19064637
Infect Immun. 2008 Feb;76(2):612-22
pubmed: 18025094
Biophys J. 2017 Jan 24;112(2):346-355
pubmed: 28122220
Biophys J. 2014 Jun 3;106(11):2493-502
pubmed: 24896129
J Am Chem Soc. 2013 Feb 6;135(5):1919-25
pubmed: 23294159
J Comput Chem. 2009 Jul 30;30(10):1545-614
pubmed: 19444816
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Biophys J. 2009 Jul 8;97(1):50-8
pubmed: 19580743
Eur J Biochem. 1974 Apr 16;43(3):533-9
pubmed: 4598752
Infect Immun. 2010 Dec;78(12):5233-43
pubmed: 20837715
J Bacteriol. 2002 Aug;184(16):4601-11
pubmed: 12142430
Tuberculosis (Edinb). 2008 Nov;88(6):526-44
pubmed: 18439872
Proteins. 2009 Feb 1;74(2):475-88
pubmed: 18655068
FEBS Lett. 2020 Aug;594(16):2598-2620
pubmed: 32170725
Mol Microbiol. 2019 Jan;111(1):82-95
pubmed: 30260060
Mol Microbiol. 2020 Sep;114(3):510-520
pubmed: 32462782
Nature. 2001 Oct 4;413(6855):523-7
pubmed: 11586360
Int J Med Microbiol. 2011 Feb;301(2):105-16
pubmed: 20951640
J Phys Chem B. 2017 Aug 17;121(32):7561-7570
pubmed: 28726410
J Phys Chem B. 2010 Jun 17;114(23):7830-43
pubmed: 20496934
J Chem Theory Comput. 2013 Jan 8;9(1):461-469
pubmed: 23316124
J Biomol NMR. 2015 Sep;63(1):59-65
pubmed: 26143069
Biochim Biophys Acta. 2015 Feb;1848(2):712-20
pubmed: 25433311
Biochemistry. 2017 Aug 22;56(33):4291-4292
pubmed: 28569055
J Comput Chem. 2014 Oct 15;35(27):1997-2004
pubmed: 25130509
Infect Immun. 2011 Dec;79(12):4984-9
pubmed: 21969002

Auteurs

Chandan Singh (C)

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Hwayoung Lee (H)

Department of Biological Sciences, Chemistry, and Bioengineering, Lehigh University, Bethlehem, PA, USA.

Ye Tian (Y)

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Sara Schesser Bartra (S)

Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA.

Suzanne Hower (S)

Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA.

Lynn M Fujimoto (LM)

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Yong Yao (Y)

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Sergey A Ivanov (SA)

State Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow Region, Russian Federation.

Rima Z Shaikhutdinova (RZ)

State Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow Region, Russian Federation.

Andrey P Anisimov (AP)

State Research Center for Applied Microbiology and Biotechnology, Obolensk, Moscow Region, Russian Federation.

Gregory V Plano (GV)

Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA.

Wonpil Im (W)

Department of Biological Sciences, Chemistry, and Bioengineering, Lehigh University, Bethlehem, PA, USA.

Francesca M Marassi (FM)

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH